API Product   :    Sorafenib Tosylate*
CEP   :    -
WCC   :    ?
Therapeutic Use    :    Antineoplastics
Originator   :    Bayer and Onyx Pharmaceuticals
CAS No.    :    284461-73-0
Trade Name.   :    NEXAVAR
Molecular Weight   :    464.825 g/mol
Molecular Formula   :    C21H16ClF3N4O3
Sorafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Sorafenib is used to treat liver cancer, thyroid cancer, or a type of kidney cancer called advanced renal cell carcinoma
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.